Quanxing Ni

8.2k total citations · 2 hit papers
141 papers, 6.0k citations indexed

About

Quanxing Ni is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Quanxing Ni has authored 141 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Oncology, 47 papers in Epidemiology and 43 papers in Surgery. Recurrent topics in Quanxing Ni's work include Pancreatic and Hepatic Oncology Research (96 papers), Neuroendocrine Tumor Research Advances (40 papers) and Pancreatitis Pathology and Treatment (25 papers). Quanxing Ni is often cited by papers focused on Pancreatic and Hepatic Oncology Research (96 papers), Neuroendocrine Tumor Research Advances (40 papers) and Pancreatitis Pathology and Treatment (25 papers). Quanxing Ni collaborates with scholars based in China, Canada and United States. Quanxing Ni's co-authors include Xianjun Yu, Chen Liu, Guopei Luo, Jin Xu, Kaizhou Jin, Jiang Long, Zhiyao Fan, Yitao Gong, Qiuyi Huang and Shunrong Ji and has published in prestigious journals such as PLoS ONE, Cancer Research and Chemical Communications.

In The Last Decade

Quanxing Ni

139 papers receiving 5.9k citations

Hit Papers

The role of necroptosis in cancer biology and therapy 2019 2026 2021 2023 2019 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Quanxing Ni China 44 3.2k 2.5k 1.7k 1.1k 1.0k 141 6.0k
Chen Liu China 36 2.8k 0.9× 1.9k 0.8× 1.4k 0.8× 941 0.9× 860 0.8× 120 4.8k
Eithne Costello United Kingdom 43 3.0k 0.9× 3.2k 1.3× 1.9k 1.1× 579 0.5× 880 0.9× 111 6.3k
Ferry A.L.M. Eskens Netherlands 43 2.9k 0.9× 2.6k 1.1× 1.2k 0.7× 1.5k 1.4× 592 0.6× 161 6.4k
Scott M. Wilhelm United States 28 2.8k 0.9× 3.5k 1.4× 1.3k 0.8× 1.6k 1.6× 1.3k 1.3× 70 9.0k
Taiping Zhang China 40 2.7k 0.9× 2.7k 1.1× 2.0k 1.2× 791 0.8× 1.0k 1.0× 219 5.6k
Liang Liu China 39 2.6k 0.8× 2.3k 0.9× 1.7k 1.0× 757 0.7× 686 0.7× 165 5.3k
Madappa N. Kundranda United States 16 2.4k 0.7× 2.5k 1.0× 1.5k 0.9× 1.4k 1.3× 901 0.9× 66 5.8k
Tae‐You Kim South Korea 37 3.3k 1.0× 3.1k 1.3× 1.8k 1.0× 2.4k 2.3× 1.5k 1.4× 150 7.6k
William G. Cance United States 55 2.9k 0.9× 4.2k 1.7× 1.8k 1.0× 940 0.9× 807 0.8× 174 9.2k
Guopei Luo China 31 2.2k 0.7× 1.5k 0.6× 1.1k 0.7× 729 0.7× 638 0.6× 90 3.7k

Countries citing papers authored by Quanxing Ni

Since Specialization
Citations

This map shows the geographic impact of Quanxing Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quanxing Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quanxing Ni more than expected).

Fields of papers citing papers by Quanxing Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quanxing Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quanxing Ni. The network helps show where Quanxing Ni may publish in the future.

Co-authorship network of co-authors of Quanxing Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Quanxing Ni. A scholar is included among the top collaborators of Quanxing Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quanxing Ni. Quanxing Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yi, Xinyue Wang, Zhiwen Xiao, et al.. (2025). Antitumor potential of polyamines in cancer. Acta Biochimica et Biophysica Sinica. 57(9). 1381–1390. 1 indexed citations
2.
Liu, Chen, Shengming Deng, Zhiwen Xiao, et al.. (2023). Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer. Discover Oncology. 14(1). 20–20. 6 indexed citations
3.
Gong, Yitao, Zhiyao Fan, Guopei Luo, et al.. (2020). <p>Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients</p>. Cancer Management and Research. Volume 12. 6727–6737. 6 indexed citations
4.
Liu, Chen, Cheng He, Kaizhou Jin, et al.. (2020). Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy. Cancer Control. 27(1). 1148351211–1148351211. 2 indexed citations
5.
Huang, Qiuyi, Haiyang Zhou, Chen Liu, et al.. (2019). Surgical Resection for Metastatic Tumors in the Pancreas: A Single-Center Experience and Systematic Review. Annals of Surgical Oncology. 26(6). 1649–1656. 17 indexed citations
6.
Fan, Zhiyao, Kun Fan, Yitao Gong, et al.. (2019). <p>The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer</p>. Cancer Management and Research. Volume 11. 8781–8788. 30 indexed citations
7.
Liang, Chen, Si Shi, Mingyang Liu, et al.. (2018). PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells. Cancer Research. 79(1). 133–145. 53 indexed citations
8.
Liang, Chen, Yi Qin, Bo Zhang, et al.. (2017). Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Research. 15(2). 201–212. 46 indexed citations
9.
Hu, Qiangsheng, Yi Qin, Bo Zhang, et al.. (2017). FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1. Oncology Reports. 38(4). 2069–2077. 26 indexed citations
10.
Gao, Heli, Liang Liu, Zihao Qi, et al.. (2017). O-6-Methylguanine-DNA Methyltransferase and Response to Alkylation Agents in Neuroendocrine Tumor: A Meta-Analysis. JOP, journal of the pancreas. 18(3). 2 indexed citations
11.
Ji, Shunrong, Yi Qin, Chen Liang, et al.. (2016). FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer. Clinical Cancer Research. 22(15). 3950–3960. 76 indexed citations
12.
Risch, Harvey A., Lingeng Lu, Jing Wang, et al.. (2016). Aspirin Use and Reduced Risk of Pancreatic Cancer. Cancer Epidemiology Biomarkers & Prevention. 26(1). 68–74. 50 indexed citations
13.
Liang, Dingkong, Si Shi, Jin Xu, et al.. (2016). New insights into perineural invasion of pancreatic cancer: More than pain. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1865(2). 111–122. 54 indexed citations
14.
Luo, Guopei, Chen Liu, Meng Guo, et al.. (2016). CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype. Cancer Letters. 385. 46–50. 20 indexed citations
15.
Xiang, Jinfeng, Liang Liu, Wenquan Wang, et al.. (2015). Metabolic tumor burden: A new promising way to reach precise personalized therapy in PDAC. Cancer Letters. 359(2). 165–168. 13 indexed citations
16.
Ni, Quanxing. (2012). Clinico-pathological characteristics and influencing factors of lymph node metastasis of pancreatic head carcinoma. Zhongguo aizheng zazhi. 1 indexed citations
17.
Yang, Feng, Chen Jin, Deliang Fu, & Quanxing Ni. (2011). Extra‐gastrointestinal stromal tumor of the pancreas: Clinical characteristics, diagnosis, treatment, and outcome. Journal of Surgical Oncology. 103(7). 739–740. 13 indexed citations
18.
Zhang, Qunhua, et al.. (2004). [Clinical analysis of 2340 cases of pancreatic cancer].. PubMed. 84(3). 214–8. 23 indexed citations
19.
Jin, Chen, Quanxing Ni, & Qinxiu Zhang. (2001). [Apoptosis of pancreatic acinar and expression of TNF-alpha mRNA, IL-10 mRNA in rats with acute pancreatitis].. PubMed. 39(8). 626–8. 2 indexed citations
20.
Ni, Quanxing. (2000). The expression of serum IL-6, IL-10, IL-12 level in gastrointestinal neoplasm and its significance.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026